EyePoint Pharmaceuticals SG&A Expense (Annual) Analysis

EyePoint Pharmaceuticals Inc (EYPT)

7.98 -0.09 (-1.12%) USD | NASDAQ | Sep 27, 16:00

7.99 +0.01 (+0.13%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2001. Upgrade now.

Date	Value
December 31, 2023	51.79M
December 31, 2022	60.32M
December 31, 2021	53.08M
December 31, 2020	46.02M
December 31, 2019	47.71M
December 31, 2018	17.08M
June 30, 2018	13.06M
June 30, 2017	11.24M
June 30, 2016	9.013M
June 30, 2015	8.056M
June 30, 2014	7.468M
June 30, 2013	7.169M

Date	Value
June 30, 2012	6.868M
June 30, 2011	8.104M
June 30, 2010	6.968M
June 30, 2009	8.791M
June 30, 2008	13.95M
June 30, 2007	12.98M
June 30, 2006	15.88M
June 30, 2005	8.880M
June 30, 2004	1.602M
June 30, 2003	0.5655M
June 30, 2002
June 30, 2001	0.377M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

46.02M

Minimum

2020

60.32M

Maximum

2022

51.78M

Average

51.79M

Median

2023

SG&A Expense (Annual) Benchmarks